Chuey Yan Lee1, Kien Ting Liu2, Hou Tee Lu1, Rosli Mohd Ali3, Alan Yean Yip Fong4,5, Wan Azman Wan Ahmad6. 1. Department of Cardiology, Sultanah Aminah Hospital, Ministry of Health, Johor Bahru, Johor, Malaysia. 2. National Heart Association of Malaysia, Kuala Lumpur, Malaysia. 3. Cardiac Vascular Sentral Kuala Lumpur, Kuala Lumpur, Malaysia. 4. Department of Cardiology, Sarawak Heart Centre, Ministry of Health, Kota Samarahan, Sarawak, Malaysia. 5. Clinical Research Centre, Sarawak General Hospital, Institute for Clinical Research, National Institute of Health, Kuching, Sarawak, Malaysia. 6. University Malaya Medical Centre, Kuala Lumpur, Malaysia.
Abstract
BACKGROUND: Sex and gender differences in acute coronary syndrome (ACS) have been well studied in the western population. However, limited studies have examined the trends of these differences in a multi-ethnic Asian population. OBJECTIVES: To study the trends in sex and gender differences in ACS using the Malaysian NCVD-ACS Registry. METHODS: Data from 24 hospitals involving 35,232 ACS patients (79.44% men and 20.56% women) from 1st. Jan 2012 to 31st. Dec 2016 were analysed. Data were collected on demographic characteristics, coronary risk factors, anthropometrics, treatments and outcomes. Analyses were done for ACS as a whole and separately for ST-segment elevation myocardial infarction (STEMI), Non-STEMI and unstable angina. These were then compared to published data from March 2006 to February 2010 which included 13,591 ACS patients (75.8% men and 24.2% women). RESULTS: Women were older and more likely to have diabetes mellitus, hypertension, dyslipidemia, previous heart failure and renal failure than men. Women remained less likely to receive aspirin, beta-blocker, angiotensin-converting enzyme inhibitor (ACE-I) and statin. Women were less likely to undergo angiography and percutaneous coronary intervention (PCI) despite an overall increase. In the STEMI cohort, despite a marked increase in presentation with Killip class IV, women were less likely to received primary PCI or fibrinolysis and had longer median door-to-needle and door-to-balloon time compared to men, although these had improved. Women had higher unadjusted in-hospital, 30-Day and 1-year mortality rates compared to men for the STEMI and NSTEMI cohorts. After multivariate adjustments, 1-year mortality remained significantly higher for women with STEMI (adjusted OR: 1.31 (1.09-1.57), p<0.003) but were no longer significant for NSTEMI cohort. CONCLUSION: Women continued to have longer system delays, receive less aggressive pharmacotherapies and invasive treatments with poorer outcome. There is an urgent need for increased effort from all stakeholders if we are to narrow this gap.
BACKGROUND: Sex and gender differences in acute coronary syndrome (ACS) have been well studied in the western population. However, limited studies have examined the trends of these differences in a multi-ethnic Asian population. OBJECTIVES: To study the trends in sex and gender differences in ACS using the Malaysian NCVD-ACS Registry. METHODS: Data from 24 hospitals involving 35,232 ACS patients (79.44% men and 20.56% women) from 1st. Jan 2012 to 31st. Dec 2016 were analysed. Data were collected on demographic characteristics, coronary risk factors, anthropometrics, treatments and outcomes. Analyses were done for ACS as a whole and separately for ST-segment elevation myocardial infarction (STEMI), Non-STEMI and unstable angina. These were then compared to published data from March 2006 to February 2010 which included 13,591 ACS patients (75.8% men and 24.2% women). RESULTS:Women were older and more likely to have diabetes mellitus, hypertension, dyslipidemia, previous heart failure and renal failure than men. Women remained less likely to receive aspirin, beta-blocker, angiotensin-converting enzyme inhibitor (ACE-I) and statin. Women were less likely to undergo angiography and percutaneous coronary intervention (PCI) despite an overall increase. In the STEMI cohort, despite a marked increase in presentation with Killip class IV, women were less likely to received primary PCI or fibrinolysis and had longer median door-to-needle and door-to-balloon time compared to men, although these had improved. Women had higher unadjusted in-hospital, 30-Day and 1-year mortality rates compared to men for the STEMI and NSTEMI cohorts. After multivariate adjustments, 1-year mortality remained significantly higher for women with STEMI (adjusted OR: 1.31 (1.09-1.57), p<0.003) but were no longer significant for NSTEMI cohort. CONCLUSION:Women continued to have longer system delays, receive less aggressive pharmacotherapies and invasive treatments with poorer outcome. There is an urgent need for increased effort from all stakeholders if we are to narrow this gap.
Authors: J S Hochman; C H McCabe; P H Stone; R C Becker; C P Cannon; T DeFeo-Fraulini; B Thompson; R Steingart; G Knatterud; E Braunwald Journal: J Am Coll Cardiol Date: 1997-07 Impact factor: 24.094
Authors: Stefan Agewall; John F Beltrame; Harmony R Reynolds; Alexander Niessner; Giuseppe Rosano; Alida L P Caforio; Raffaele De Caterina; Marco Zimarino; Marco Roffi; Keld Kjeldsen; Dan Atar; Juan C Kaski; Udo Sechtem; Per Tornvall Journal: Eur Heart J Date: 2017-01-14 Impact factor: 29.983
Authors: Glenn N Levine; Eric R Bates; James C Blankenship; Steven R Bailey; John A Bittl; Bojan Cercek; Charles E Chambers; Stephen G Ellis; Robert A Guyton; Steven M Hollenberg; Umesh N Khot; Richard A Lange; Laura Mauri; Roxana Mehran; Issam D Moussa; Debabrata Mukherjee; Henry H Ting; Patrick T O'Gara; Frederick G Kushner; Deborah D Ascheim; Ralph G Brindis; Donald E Casey; Mina K Chung; James A de Lemos; Deborah B Diercks; James C Fang; Barry A Franklin; Christopher B Granger; Harlan M Krumholz; Jane A Linderbaum; David A Morrow; L Kristin Newby; Joseph P Ornato; Narith Ou; Martha J Radford; Jacqueline E Tamis-Holland; Carl L Tommaso; Cynthia M Tracy; Y Joseph Woo; David X Zhao; Jonathan L Halperin; Glenn N Levine; Jeffrey L Anderson; Nancy M Albert; Sana M Al-Khatib; Kim K Birtcher; Biykem Bozkurt; Ralph G Brindis; Joaquin E Cigarroa; Lesley H Curtis; Lee A Fleisher; Federico Gentile; Samuel Gidding; Mark A Hlatky; John Ikonomidis; Jose Joglar; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Duminda N Wijeysundera Journal: Catheter Cardiovasc Interv Date: 2016-05 Impact factor: 2.692
Authors: Hou Tee Lu; Rusli Nordin; Wan Azman Wan Ahmad; Chuey Yan Lee; Robaayah Zambahari; Omar Ismail; Houng Bang Liew; Kui Hian Sim Journal: Glob Heart Date: 2014-12
Authors: J B Kostis; A C Wilson; K O'Dowd; P Gregory; S Chelton; N M Cosgrove; A Chirala; T Cui Journal: Circulation Date: 1994-10 Impact factor: 29.690